Vascular Biogenics (STU:0VB) Change In Inventory: €0.00 Mil (TTM As of Jun. 2023)

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

What is Vascular Biogenics Change In Inventory?

Vascular Biogenics STU:0VB 10 Change In Inventory is €0.00 Mil as of Jun. 2023. GuruFocus rates STU:0VB with a GF Score™ of 10/100. The stock has 5 warning signs investors should review.

Vascular Biogenics's change in inventory for the quarter that ended in Jun. 2023 was €0.00 Mil. It means Vascular Biogenics's inventory stayed the same from Mar. 2023 to Jun. 2023 .

Vascular Biogenics's change in inventory for the fiscal year that ended in Dec. 2022 was €0.00 Mil. It means Vascular Biogenics's inventory stayed the same from Dec. 2021 to Dec. 2022 .

Vascular Biogenics's Total Inventories for the quarter that ended in Jun. 2023 was €0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Vascular Biogenics (STU:0VB) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Vascular Biogenics's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0	/	0	*	365 / 4
	=	N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Vascular Biogenics's Inventory Turnover for the quarter that ended in Jun. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0	/	0
	=	N/A

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Vascular Biogenics's Inventory to Revenue for the quarter that ended in Jun. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	0
	=	N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vascular Biogenics Change In Inventory Related Terms

Vascular Biogenics Change In Inventory Historical Data

* Premium members only.

The historical data trend for Vascular Biogenics's Change In Inventory can be seen below:

Vascular Biogenics Change In Inventory Chart

Vascular Biogenics Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Inventory

Get a 7-Day Free Trial

0.00

Vascular Biogenics Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Change In Inventory	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

Vascular Biogenics Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Frequently Asked Questions Learn more about Change In Inventory →

What does a Change In Inventory of €0.00 Mil mean?

Vascular Biogenics (STU:0VB) has a Change In Inventory of €0.00 Mil as of Jun. 2023. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Vascular Biogenics and its competitors.

Is Vascular Biogenics' Change In Inventory too high?

Vascular Biogenics' current Change In Inventory is €0.00 Mil. Overall, Vascular Biogenics has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.

How does Vascular Biogenics' Change In Inventory compare to MBIO and GNPX?

Vascular Biogenics' Change In Inventory of €0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Change In Inventory for a Biotechnology company?

A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Change In Inventory mean?

A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Vascular Biogenics and its competitors. Vascular Biogenics's current Change In Inventory is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Vascular Biogenics stock overvalued right now?

Vascular Biogenics (STU:0VB) has a current Change In Inventory of €0.00 Mil. The current Change In Inventory is €0.00 Mil. Vascular Biogenics' overall GF Score™ is 10/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Change In Inventory calculated?

Change In Inventory is calculated from a company's financial statements. For Vascular Biogenics (STU:0VB), the current Change In Inventory is €0.00 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vascular Biogenics Business Description

Industry Healthcare Biotechnology

Comparable Companies MBIO GNPX LEXX OTLC SRZN LABP TNXP SNTI LPCN ALZN OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX

Address 8 HaSatat Street, Modi’in, ISR, 7178106

Website https://www.vblrx.com

Vascular Biogenics Ltd is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of first-in-class treatments for cancer. The lead product candidate of the company is VB-111 which is a gene-based biologic which is being developed for solid tumor indications for recurrent glioblastoma, an aggressive form of brain cancer. The company is also engaged in conducting a program targeting anti-inflammatory diseases, based on the use of Lecinoxoid platform technology. The product brands of the company include VTS, Vascular Targeting Systems, Vbl, Vascular Biogenics And Vascular Therapeutics.